eCARTv5 Clinical Deterioration Suite (“eCART”) vs DeepCT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Deep01 Limited

AI Verdict

Tool A, eCARTv5, is designed for continuous, real-time prediction of general clinical deterioration in hospitalized adult patients using EHR data. In contrast, Tool B, DeepCT, is an AI solution focused on the rapid detection and triage of specific brain abnormalities, such as intracranial hemorrhage, from CT scans. While both are FDA-cleared AI-powered clinical decision support tools, they address distinct clinical problems and utilize different data sources, making them adjacent rather than direct competitors.

Choose eCARTv5 Clinical Deterioration Suite (“eCART”) if…

Choose eCARTv5 if your primary goal is to proactively prevent clinical deterioration in hospitalized adult patients across your facility. This tool is ideal for institutions seeking continuous, AI-powered risk assessment integrated with EHRs to guide care pathways and optimize resource utilization by identifying patients at risk of ICU transfer or death hours in advance.

View eCARTv5 Clinical Deterioration Suite (“eCART”) →

Choose DeepCT if…

Choose DeepCT if your priority is to enhance the speed and accuracy of diagnosing acute neurological conditions like intracranial hemorrhage from non-contrast CT scans in emergency or radiology departments. This solution is best suited for improving emergency workflow by providing rapid AI-powered detection, worklist prioritization, and detailed quantification of findings for time-sensitive cases.

View DeepCT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature eCARTv5 Clinical Deterioration Suite (“eCART”) DeepCT
Pricing Contact vendor for tailored quote. Contact for details
Deployment Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems. Cloud-based, Hybrid solution, Locally on dedicated hardware, Integration in standard reading environment (PACS), Stand-alone third party application, Stand-alone web-based
FDA Status 1 AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eCARTv5 Clinical Deterioration Suite (“eCART”)

eCART is designed to minimize false alarms and decrease clinician workload, integrating directly into EHRs with embedded clinical pathways to guide care teams. This focus on reducing cognitive burden and providing actionable guidance within existing workflows makes it highly usable for a broad range of clinical staff. DeepCT, while efficient for radiologists in prioritizing imaging, has a more specialized workflow impact.

Clinical Value

eCARTv5 Clinical Deterioration Suite (“eCART”)

eCART offers broad clinical value by continuously assessing and predicting all-cause clinical deterioration in hospitalized adult patients, aiming to decrease mortality and length of stay across a wide patient population. While DeepCT provides critical, time-sensitive detection for specific neurological conditions like ICH, significantly reducing emergency department length of stay, eCART's impact spans a larger and more diverse patient cohort within the hospital.

Pricing & Value

Tie

Both AgileMD's eCART and Deep01's DeepCT explicitly state that pricing details are not publicly disclosed and require direct contact with the vendor for a tailored quote. Without any transparent pricing information, it is impossible to conduct a head-to-head comparison of their value propositions based on cost.

Enterprise Readiness

DeepCT

DeepCT offers highly flexible deployment options, including cloud, hybrid, local hardware, and integration with PACS or as a stand-alone application, which caters to diverse enterprise IT infrastructures. Furthermore, its extensive international regulatory clearances (US, Taiwan, Japan, CE, ISO13485, Thailand, Hong Kong, Malaysia) demonstrate a broader readiness for global enterprise adoption compared to eCART's strong, but primarily US-focused, EHR integration.

Innovation

DeepCT

DeepCT demonstrates significant innovation by being the first deep learning software to obtain US FDA clearance in Asia Pacific and the first to obtain Taiwan FDA approval using deep learning technology. Its advanced features for rapid detection, segmentation, and quantification of multiple brain abnormalities from CT scans, along with worklist prioritization, showcase cutting-edge application of AI in radiology. While eCART is innovative in its continuous, all-cause clinical deterioration prediction, DeepCT's pioneering regulatory achievements and specialized image analysis capabilities give it an edge in innovation.

Support & Docs

eCARTv5 Clinical Deterioration Suite (“eCART”)

AgileMD's eCART explicitly details its support offerings, including 'Help & Support,' 'System Status,' 'Vulnerability Disclosure Policy,' and 'AgileMD Forum Guidelines' on its website. It also boasts a substantial body of peer-reviewed publications and emphasizes robust implementation support, reporting, and benchmarking capabilities. DeepCT, while listing publications and contact information, does not provide comparable explicit details regarding its support infrastructure or comprehensive documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature eCARTv5 Clinical Deterioration Suite (“eCART”) DeepCT
Name eCARTv5 Clinical Deterioration Suite (u0093eCARTu0094) DeepCT
Company AgileMD Deep01 Limited
Description FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways. FDA-cleared AI software for the rapid detection and triage of suspected intracranial hemorrhage (ICH) and other brain abnormalities from non-contrast CT scans, aiming to improve emergency workflow and patient outcomes.
Primary Function AI-powered clinical deterioration prediction and continuous patient risk assessment (death or ICU transfer). Rapid detection and triage of suspected intracranial hemorrhage (ICH) and other brain abnormalities from non-contrast CT scans.
Key Specialties Critical Care, Emergency Medicine, Hospital Medicine Emergency Medicine, Neurology, Radiology

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (“eCART”) and DeepCT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

eCARTv5 is designed to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways. DeepCT, in contrast, focuses on the rapid detection and triage of suspected intracranial hemorrhage and other brain abnormalities from non-contrast CT scans to improve emergency workflow and patient outcomes.
eCARTv5 is a cloud-based SaaS that integrates directly into Electronic Health Record (EHR) systems, utilizing up to 97 real-time variables from patient data. DeepCT offers more flexible deployment options, including cloud-based, hybrid solutions, local hardware, or integration in standard reading environments (PACS), and specifically analyzes non-contrast CT images of the brain.
eCARTv5 provides an eCART score, risk designation, and embedded clinical pathways to guide care, acting as an early warning system hours before critical illness. DeepCT offers detection, segmentation, and quantification of intracranial hemorrhage, notifications to clinicians, worklist prioritization for time-sensitive cases, and detection of other conditions like midline shift, acute stroke, traumatic brain injury, and fractures.
eCARTv5 aims to maximize early identification of at-risk patients, minimize false alarms, and decrease clinician workload by predicting and mitigating the risk of clinical deterioration in hospitalized adult patients. DeepCT aims to improve emergency workflow and patient outcomes by providing rapid and accurate detection and triage of suspected intracranial hemorrhage and other brain abnormalities from CT scans.
AI Tool Finder
AI-powered search. Results may not be comprehensive.